ctrl K

Price Alert

Chemomab Therapeutics Ltd... (CMMB)

NASDAQ: CMMB · Real-Time Price · USD

0.93

-0.01 (-1.06%)

At close: Aug 19, 2025, 3:59 PM

1.00

7.47%

After-hours: Aug 19, 2025, 07:31 PM EDT

Chemomab Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	6.07M	9.29M	13.52M	14.69M
Short-Term Investments	8.2M	10.49M	26.37M	46.48M
Long-Term Investments	n/a	n/a	n/a	55K
Other Long-Term Assets	378.38K	559K	733K	908K
Receivables	263K	289K	459K	179K
Inventory	n/a	n/a	n/a	-47.5M
Other Current Assets	76K	76K	77K	n/a
Total Current Assets	16.04M	20.9M	41.74M	62.69M
Property-Plant & Equipment	539K	695K	594K	702K
Goodwill & Intangibles	6.62K	n/a	n/a	n/a
Total Long-Term Assets	924K	1.25M	1.33M	1.67M
Total Assets	16.96M	22.15M	43.06M	64.35M
Account Payables	666K	516K	1.69M	1.34M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	874K	823K	n/a	n/a
Total Current Liabilities	3.22M	4.84M	6.75M	2.65M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	209K	316K	91K	237K
Total Liabilities	3.43M	5.15M	6.84M	2.89M
Total Debt	324K	392K	214K	343K
Common Stock	n/a	n/a	n/a	n/a
Retained Earnings	-102.62M	-88.68M	-63.82M	-36.17M
Comprehensive Income	0.00	n/a	-0.00	0.00
Shareholders Equity	13.54M	17M	36.22M	61.47M
Total Investments	8.2M	10.49M	26.37M	46.48M